FDA Warning Letter — Azurity Pharmaceuticals, Inc.
The FDA took a Warning Letter action against Azurity Pharmaceuticals, Inc. on Sep 20, 2024 (Woburn, MA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action details
- Facility
- Azurity Pharmaceuticals, Inc.
- Date
- Sep 20, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Woburn, MA (United States)